Structural basis of broad ebolavirus neutralization by a human survivor antibody.
Structural basis of broad ebolavirus neutralization by a human survivor antibody.
复制标题
人类幸存者抗体广泛中和埃博拉病毒的结构基础。
DOI:
10.1038/s41594-019-0191-4
复制
发表时间:
2019
影响因子:
16.8
通讯作者:
Dye
中科院分区:
文献类型:
--
作者:
West,BrandynR;Wec,AnnaZ;Moyer,CrystalL;Fusco,MarnieL;Ilinykh,PhilippA;Huang,Kai;Wirchnianski,ArielS;James,RebekahM;Herbert,AndrewS;Hui,Sean;Goodwin,Eileen;Howell,KatieA;Kailasan,Shweta;Aman,MJavad;Walker,LauraM;Dye
The structural features that govern broad-spectrum activity of broadly neutralizing anti-ebolavirus antibodies (Abs) outside of the internal fusion loop epitope are currently unknown. Here we describe the structure of a broadly neutralizing human monoclonal Ab (mAb), ADI-15946, which was identified in a human survivor of the 2013–2016 outbreak. The crystal structure of ADI-15946 in complex with cleaved Ebola virus glycoprotein (EBOV GPCL) reveals that binding of the mAb structurally mimics the conserved interaction between the EBOV GP core and its glycan cap β17–β18 loop to inhibit infection. Both endosomal proteolysis of EBOV GP and binding of mAb FVM09 displace this loop, thereby increasing exposure of ADI-15946’s conserved epitope and enhancing neutralization. Our work also mapped the paratope of ADI-15946, thereby explaining reduced activity against Sudan virus, which enabled rational, structure-guided engineering to enhance binding and neutralization of Sudan virus while retaining the parental activity against EBOV and Bundibugyo virus.